SCHEMBL22371450

SCHEMBL22371450

CCOC(=O)CCCNc1ccc2cc(-c3nc4ccc(C(=O)O)cc4o3)c(=O)oc2c1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ELANE P08246 1/20 0.45
▸ MAPT P10636 8/20 0.42
▸ TP53 P04637 3/20 0.42
▸ POLB P06746 1/20 0.42
▸ TDP1 Q9NUW8 1/20 0.42
▸ TOP2A P11388 1/20 0.41
▸ MEN1 O00255 1/20 0.41
▸ KMT2A Q03164 1/20 0.41
▸ PDE5A O76074 1/20 0.39
▸ MAOA P21397 2/20 0.38
▸ TTR P02766 1/20 0.38
▸ ALB P02768 1/20 0.38
▸ CNR1 P21554 1/20 0.38
▸ DRD1 P21728 1/20 0.38
▸ OPRD1 P41143 1/20 0.38
▸ PDE4D Q08499 1/20 0.38
▸ PDE3A Q14432 1/20 0.38
▸ MIF P14174 2/20 0.38
▸ KDM4E B2RXH2 3/20 0.36
▸ NPC1 O15118 3/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22371423 0.93 ELANE (0.45) ELANEMAPTTP53POLBTDP1
SCHEMBL31135851 0.93 ELANE (0.45) ELANEMAPTTP53POLBTDP1
SCHEMBL25997472 0.79 HPSE (0.49) MAPTTP53POLBTDP1MIF
SCHEMBL22371413 0.76 MAPT (0.57) MAPTTP53POLBTDP1MEN1
SCHEMBL22371415 0.76 HSPD1 (0.40) MAPTTP53POLBTDP1MIF
SCHEMBL31135859 0.76 HSPD1 (0.40) MAPTTP53POLBTDP1MIF
SCHEMBL22371405 0.75 MAPT (0.53) MAPTTP53POLBTDP1MEN1
SCHEMBL24239995 0.74 MIF (0.43) MAPTTP53POLBTDP1MEN1
SCHEMBL26972163 0.73 KDM4E (0.55) MAPTTP53MEN1KMT2AKDM4E
SCHEMBL22371421 0.72 AGPAT2 (0.46) MAPTTP53POLBTDP1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250002994-A1 TERTIARY AMINE SUBSTITUTED COUMARIN COMPOUNDS AND USES AS FLUORESCENT LABELS ILLUMINA CAMBRIDGE LIMITED (GB) 2025-01-02 — — US disclosed
US-12110546-B2 Tertiary amine substituted coumarin compounds and uses as fluorescent labels ILLUMINA CAMBRIDGE LIMITED (GB) 2024-10-08 — — US disclosed
US-12031178-B2 Cyclooctatetraene containing dyes and compositions ILLUMINA CAMBRIDGE LIMITED (GB) 2024-07-09 — — US disclosed
US-20230265502-A1 CYCLOOCTATETRAENE CONTAINING DYES AND COMPOSITIONS ILLUMINA CAMBRIDGE LIMITED (GB) 2023-08-24 — — US disclosed
US-20220049292-A1 MULTIPLEXED FLUORESCENT DETECTION OF ANALYTES ILLUMINA CAMBRIDGE LIMITED (GB) 2022-02-17 — — US disclosed
US-20220049292-A1 MULTIPLEXED FLUORESCENT DETECTION OF ANALYTES ILLUMINA CAMBRIDGE LIMITED (GB) 2022-02-17 — — US disclosed
US-20200277670-A1 TERTIARY AMINE SUBSTITUTED COUMARIN COMPOUNDS AND USES AS FLUORESCENT LABELS ILLUMINA CAMBRIDGE LIMITED (GB) 2020-09-03 — — US disclosed
US-20200277670-A1 TERTIARY AMINE SUBSTITUTED COUMARIN COMPOUNDS AND USES AS FLUORESCENT LABELS ILLUMINA CAMBRIDGE LIMITED (GB) 2020-09-03 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12110546-B2 Tertiary amine substituted coumarin compounds and uses as fluorescent labels FBL, NAT10, DNMT3A ELANE 3468/4885MAPT 1401/4885TP53 478/4885
US-20200277670-A1 TERTIARY AMINE SUBSTITUTED COUMARIN COMPOUNDS AND USES AS FLUORESCENT LABELS FBL, NAT10, DNMT3A ELANE 3468/4885MAPT 1401/4885TP53 478/4885
US-20250002994-A1 TERTIARY AMINE SUBSTITUTED COUMARIN COMPOUNDS AND USES AS FLUORESCENT LABELS FBL, NAT10, DNMT3A ELANE 3468/4885MAPT 1401/4885TP53 478/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback